Diallo A M, Grauwin M Y, Hirzel C B, Lienhardt C, Tiendrébéogo A, Groupe D
Institut Marchoux, Bamako, Mali.
Acta Leprol. 1996;10(1):29-35.
Patients treated and cured on the bacteriological level by multidrug therapy may nevertheless present handicaps, such as deformities resulting from the disease, which have personal and social consequences. It is actually the handicap and disability from which most patients suffer and which concern populations. The number of persons suffering from such handicaps worldwide has been estimated at 4 million. Therefore, the main goal is to gradually integrate the activities of the prevention of disabilities and physical rehabilitation programme (PIRP) into the national leprosy control programme (PNL). The persons involved in the implementation of the programme outline the activities planned under the PIRP, detailed objectives, priorities, the means by which they will be implemented, the content of training programmes, assessment criteria and documents available.
通过多药疗法在细菌学层面得到治疗和治愈的患者仍可能存在残疾,例如由疾病导致的畸形,这会带来个人和社会后果。实际上,大多数患者遭受的是残疾以及由此产生的功能障碍,这涉及到广大人群。据估计,全球患有此类残疾的人数达400万。因此,主要目标是逐步将残疾预防和身体康复计划(PIRP)的活动纳入国家麻风病控制计划(PNL)。参与该计划实施的人员概述了PIRP计划开展的活动、详细目标、优先事项、实施方式、培训计划内容、评估标准以及可用文件。